TAK

NYSE 已收盘

Takeda Pharmaceutical Company Limited

16.56 USD
-0.16-1.60%
盘后 17.20 +0.64%
2026-07-31
市值
$53.57B
市盈率
EPS
-0.64
股息率
2.88%
52 周区间
12.99 – 18.90
成交量
5.91M
Beta
0.09
目标价
21.63
52W 低 12.9952W 高 18.90
价格走势

公司简介

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Takhzyro, Advate, Elaprase, Replagal, Vpriv, Adynovate/Adynovi, Livtencity, ADZYNMA, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Flexbumin, Adcetris, Leuplin/Enan...